Carcinogenicity of proposed cancer chemotherapeutic agents with stilbene-arylnitrosamine structures
Related Experiment Videos
Journal of the National Cancer Institute
|October 1, 1973
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Rapid detection of streptococcal pharyngitis.
Canadian family physician Medecin de famille canadien·2011
Use of prostheses and footwear in 110 inner-city partial-foot amputees.
Journal of the American Podiatric Medical Association·2001
Chemoprevention of cancer: a brief review.
In vivo (Athens, Greece)·2000
Effect of tea extracts, polyphenols, and epigallocatechin gallate on azoxymethane-induced colon cancer.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)·1998
Dietary fat and risk of chronic disease: mechanistic insights from experimental studies.
Journal of the American Dietetic Association·1997
Head and neck cancer in older adults: biological aging, treatment tolerance, and survivorship.
Journal of the National Cancer Institute·2026
Employment after curative breast cancer treatment: the breast cancer and the workforce cohort study.
Journal of the National Cancer Institute·2026
Modeling the survival impact of the Inflation Reduction Act out-of-pocket cap in multiple myeloma.
Journal of the National Cancer Institute·2026
A clinical model incorporating early lymphocyte dynamics in HER2-positive breast cancer.
Journal of the National Cancer Institute·2026
Efficacy and toxicity of antibody-drug conjugates in older adults with breast cancer: A systematic review and meta-analysis.
Journal of the National Cancer Institute·2026
Foundation models for cancer: advancing diagnosis, prognosis, and treatment response-an NCI workshop report.
Journal of the National Cancer Institute·2026
Practice patterns in myeloma bone disease: a multi-center survey.
Frontiers in oncology·2026
Blockade of the calpain-1/HSP90/TGF-β1 axis by Astragaloside IV ameliorates bleomycin-induced pulmonary fibrosis.
Frontiers in pharmacology·2026